Recent advances in nanoparticles-based platforms targeting the pd-1/pd-l1 pathway for cancer treatment

HIGHLIGHTS

• who: Xin Yu et al. from the Department of Oncology, Shanghai Pulmonary Hospital and Thoracic Cancer Institute, Tongji University have published the article: Recent Advances in NanopArticles-Based Platforms Targeting the PD-1/PD-L1 Pathway for Cancer Treatment, in the Journal: Pharmaceutics 2022, 14, 1581. of /2022/
• what: This research explored a potential approach to improve the clinical outcomes of patients with GBM and needed to be further verified.
• future: These results provide the authors with a new prospect for developing oral delivery systems in the future. Of all more research is . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.